Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 33 checked references that resolve
resolves10.3390/nu10101557Mediterranean Lifestyle in Relation to Cognitive Health: Results from the HELIAD Study
resolves10.1017/S0007114517001982Nutrient intake and dietary changes during a 2-year multi-domain lifestyle intervention among older adults: secondary analysis of the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) randomised controlled trial
resolves10.3233/JAD-130998Targeting Synaptic Dysfunction in Alzheimer's Disease by Administering a Specific Nutrient Combination
resolves10.3233/JAD-2011-110635Neuroprotective Effects of a Specific Multi-Nutrient Intervention Against Aβ42-Induced Toxicity in Rats
resolves10.3233/JAD-2012-112039A Specific Multi-Nutrient Diet Reduces Alzheimer-Like Pathology in Young Adult AβPPswe/PS1dE9 Mice
resolves10.1371/journal.pone.0075393Effects of Specific Multi-Nutrient Enriched Diets on Cerebral Metabolism, Cognition and Neuropathology in AβPPswe-PS1dE9 Mice
resolves10.1016/j.jnutbio.2013.09.015Special lipid-based diets alleviate cognitive deficits in the APPswe/PS1dE9 transgenic mouse model of Alzheimer's disease independent of brain amyloid deposition
resolves10.1194/jlr.R076331Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention
resolves10.3233/JAD-2012-121189Efficacy of Souvenaid in Mild Alzheimer's Disease: Results from a Randomized, Controlled Trial
resolves10.1186/alzrt224The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s disease
resolves10.1016/S1474-4422(17)30332-024-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial
resolves10.14283/jpad.2019.33Alzheimer's Disease Composite Score: a Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer's Disease
resolves10.1186/s13195-015-0134-1Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer’s disease
resolves10.1186/s12874-019-0791-zUsing joint models to disentangle intervention effect types and baseline confounding: an application within an intervention study in prodromal Alzheimer’s disease with Fortasyn Connect
resolves10.18637/jss.v035.i09<b>JM</b>: An<i>R</i>Package for the Joint Modelling of Longitudinal and Time-to-Event Data
resolves10.1016/S0140-6736(16)30950-3Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial
resolves10.1002/sim.2249Shared parameter models for the joint analysis of longitudinal data and event times
resolves10.1201/b12208Joint Models for Longitudinal and Time-to-Event Data
resolves10.1038/psp.2013.54Modeling Alzheimer's Disease Progression Using Disease Onset Time and Disease Trajectory Concepts Applied to CDR‐SOB Scores From ADNI
resolves10.3233/JAD-132090Predicting the Time to Clinically Worsening in Mild Cognitive Impairment Patients and its Utility in Clinical Trial Design by Modeling a Longitudinal Clinical Dementia Rating Sum of Boxes from the ADNI Database
resolves10.2147/NDT.S62323Disease progression model for Clinical Dementia Rating&ndash;Sum of Boxes in mild cognitive impairment and Alzheimer&rsquo;s subjects from the Alzheimer&rsquo;s Disease Neuroimaging Initiative
resolves10.1212/WNL.55.4.484Rates of hippocampal atrophy correlate with change in clinical status in aging and AD
resolves10.1136/jnnp.2003.029074Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease
resolves10.3233/JAD-141305Tolerability and Safety of Souvenaid in Patients with Mild Alzheimer's Disease: Results of Multi-Center, 24-Week, Open-Label Extension Study
The 4 references without a DOI — listed, not checked
no DOI — not checkedRisk Reduction of Cognitive Decline and Dementia: WHO Guidelines
no DOI — not checkedEndpoints for pre‐dementia AD trials: a report from the EU/US/CTAD Task Force
no DOI — not checkedFINGER: The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) (FINLAND). Available at:http://wwfingers.com/finger/. Accessed December 13 2019.
no DOI — not checkedMIND‐AD: MIND‐AD: Multimodal preventive trials for Alzheimer's Disease: towards multinational strategies (MIND‐AD) trial. (SWEDEN FINLAND FRANCE GERMANY). Available at:http://wwfingers.com/mind-ad/. Accessed December 13 2019.
checked 2026-07-22 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.